Skip to main content

carmustine

Generic: CARMUSTINE·Brand: BICNU, BiCNU, CARMUSTINE, GLIADEL

carmustine: 3 clinical trials tracked.

carmustine evidence translation

What we can confirm

3 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about carmustine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence4 indications · 1 study sponsors
Clinical Trial Registry Records (3)

A Randomized Phase 2 Study of Carmustine Formulated With and Without Ethanol as Part of BEAM Chemotherapy Conditioning for Subjects With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (AHCT)

NCT06915246Registry updated 2026-03-27·Phase 2·VVUS
Recruiting

Primary endpoint: Evaluation of infusion-related toxicities

InterventionalRandomizedopen49 targetStarted 2025-03Completion 2027-044 sites · United StatesVIVUS LLC

A Three-part, Phase I/II Dose-Escalation Study to Define the Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 With Subsequent Extension of Optimal Dose in Recurrent GBM Subjects

NCT03382977Registry updated 2026-05-08·Phase 1/Phase 2
Terminated

Primary endpoint: Dose limiting toxicity (DLT) occurring during Part A of the study

Interventionalopen70 targetStarted 2017-12Completion 2025-0812 sites · United StatesVBI Vaccines Inc.

A Multi-center Randomized Phase II Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT02570542Registry updated 2025-11-26·Phase 2
Active, not recruiting

Primary endpoint: progression-free survival (PFS)

InterventionalRandomizedopen59 targetStarted 2015-10Completion 2026-1014 sites · United StatesMemorial Sloan Kettering Cancer Center